Bausch Health Companies (BHC) Short-term Investments (2009 - 2026)
Bausch Health Companies (BHC) reported Short-term Investments of $13.0 million for Q1 2026, down 43.48% on a YoY basis from $23.0 million in Q1 2025, and down 18.75% sequentially from $16.0 million in Q4 2025.
Bausch Health Companies (BHC) Short-term Investments (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 15 years of Short-term Investments data on file, last reported at $13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 43.48% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (down 43.48% YoY), and the FY2025 full-year result was $16.0 million, down 20.0% from the prior year.
- Short-term Investments declined to $13.0 million in Q1 2026, from $16.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $1.2 billion in Q2 2022 to a low of $9.0 million in Q2 2023.
- A 5-year average of $160.4 million and a median of $20.0 million in 2023 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments slumped 99.26% in 2023 and soared 211.11% in 2024, its largest moves.
- Tracing BHC's Short-term Investments over 5 years: stood at $27.0 million in 2022, then slumped by 44.44% to $15.0 million in 2023, then jumped by 33.33% to $20.0 million in 2024, then fell by 20.0% to $16.0 million in 2025, then slipped by 18.75% to $13.0 million in 2026.
- Business Quant data shows BHC's Short-term Investments at $13.0 million in Q1 2026, $16.0 million in Q4 2025, and $32.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Sep 30, 2025 | 32.00 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 23.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 31.00 Mn |
| Jun 30, 2024 | 28.00 Mn |
| Mar 31, 2024 | 22.00 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Dec 31, 2022 | 27.00 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 1.22 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Sep 30, 2021 | 1.21 Bn |
| Jun 30, 2021 | 1.21 Bn |
| Mar 31, 2021 | 1.21 Bn |